FILTER
FILTERED INTERVIEW RESULTS
James Sapirstein
CHAIRMAN, PRESIDENT AND CEO, FIRST WAVE BIOPHARMA
"I believe that in the near future we will be able to effectively control the Covid virus with therapeutics."
Arda Ural
PARTNER & EY AMERICAS INDUSTRY MARKETS LEADER, HEALTH SCIENCES AND WELLNESS
"Our primary objective is to pivot to areas that our clients are focusing on, such as digitalization, ESG and supply chain management."
Jay Shukla
PRESIDENT AND CEO, NIVAGEN PHARMACEUTICALS, INC.
"Nivagen has excellent connections and market access, and we are always looking to in-license FDA-approved products that leverage our expertise in launching in the US market."
Kendalle O’Connell
PRESIDENT AND COO, MASSBIO
"MassBio remains focused on providing the necessary support to help companies succeed so we can continue to stay the best place in the world for life sciences."
Emer Leahy
PRESIDENT & CEO, PSYCHOGENICS
"The main trait we are looking for in partners is access to interesting chemical libraries where, combining good chemistry with our platforms, we can identify novel treatments for neuropsychiatric disorders."
Chris Garabedian
CHAIRMAN AND CEO, XONTOGENY
"People are realizing that our sector may need to be more discerning in deciding which companies are worthy and mature enough to bring to the public markets."
Michael Quirmbach
CEO & PRESIDENT, CORDENPHARMA
"Through our growing network of cGMP facilities across Europe and the US, we aim to continue to translate complex processes and projects at any stage of development into high-value products."
Satya Vadlamani
CHAIRPERSON & MANAGING DIRECTOR, MURLI KRISHNA PHARMA PVT LTD
"We established a dynamic drug delivery systems (DDS) company focused on providing a range of effective solutions to optimize the delivery of pharmaceutical products."
Ben Howard
COO, AMERICAN MINING SERVICES
"AMS was established in Salt Lake City in August 2017 to provide both drilling tools and technical expertise to suit any specific drilling projects needs."
John E. Watson
CHAIRMAN & CEO, NV GOLD CORPORATION
“NV Gold looks for deposits that have not been explored in the traditional sense of soil sampling and geologic mapping at surface outcrops.”
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
